Logo

ProMetic Closes CA$23M in Financing

Jan 09, 2004

NEW YORK, Jan. 9 (GenomeWeb News) - Montreal, Canada-based ProMetic announced today that it has closed CA$23 million in financing after underwriters exercised an over-allotment option that entitlted them to purchase an additional 1.6 million shares over the original 10.5 million they had already purchased as of Dec. 24.

 

The over-allotment transaction is scheduled to close on Jan. 16.

 

The underwriters included Loewen, Ondaatje, McCutcheon, Sprott Securities, Dundee Securities, and Canaccord Capital.

Breaking News
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.